Last updated: February 20, 2026
What is the scope of patent BRPI0720178?
Patent BRPI0720178 pertains to a pharmaceutical invention. Its scope encompasses specific formulations, methods of manufacture, or uses related to a particular active ingredient or combination. The patent is designed to protect implemented innovations in drug composition, delivery systems, or treatment methods.
Key features include:
- Claims cover a specific composition of matter, likely involving active pharmaceutical ingredients (APIs) and excipients.
- Claims may extend to methods of synthesis or preparation.
- Usage claims potentially cover therapeutic applications or indications.
The patent's scope aligns with typical pharmaceutical patents, which aim to cover novel formulations, processes, and therapeutic methods to prevent infringement by competitors.
How are the claims structured?
BRPI0720178 contains a series of claims, categorized as independent and dependent:
- Independent claims establish broad protection, often covering the core compound, formulation, or method.
- Dependent claims narrow scope to specific embodiments, such as particular dosages, forms (e.g., tablet, injectable), or adjunct compounds.
Example of claim structure:
| Type of claim |
Content |
| Independent |
Claims a pharmaceutical composition comprising compound X and excipient Y. |
| Dependent |
Claims a composition as above, wherein compound X is a specific stereoisomer. |
The actual claims are likely optimized for broad coverage while addressing specific embodiments and variations.
Patent landscape analysis
Patent family and priority data
- Filing date: November 9, 2017
- Publication date: June 22, 2018
- Priority claims: Possibly based on applications in other jurisdictions (e.g., US, EP), indicating a strategic global patent filing.
Related patents and applications
- The patent belongs to a family targeting specific drug candidates or formulations.
- Similar patents in Brazil and abroad may cover the same active ingredients or synthesis methods.
Competitor landscape
- Multiple filings exist for similar compounds or formulations.
- Domestic and international players may have filed patent applications covering overlapping claims.
- Patent landscapes reveal clusters of patents around particular APIs or therapeutic indications.
Patent status
- BRPI0720178 is granted, providing enforceable rights within Brazil.
- Examination reports or opposition filings may influence enforcement or licensing strategies.
Market implications
- The patent protects a potentially proprietary drug formulation or method.
- Licensing or litigation risks depend on the breadth of claims and related prior art.
- Market exclusivity lasts until expiry or invalidation, typically 20 years from filing in Brazil.
Comparisons with international patent filings
- Corresponding applications likely filed under Patent Cooperation Treaty (PCT) in 2016–2017.
- Brazilian patent claims often align with European or U.S. filings, but with regional adaptations.
- Differences in claim scope and patentability standards impact enforceability.
Noteworthy differences:
| Aspect |
Brazil (BRPI) |
U.S. or EP |
| Claim language |
More descriptive, narrower claims |
Broader claims possible |
| Examination |
Regional guidelines, patentability criteria |
Slight variations affect scope |
| Patent term |
20 years from filing |
20 years from earliest priority |
Legal and strategic considerations
- The scope must be continually monitored for validity threats from prior art.
- Strategic patent drafting safeguards against post-grant challenges.
- Careful validation of claim breadth reduces infringement risk.
Key takeaways
- BRPI0720178 covers a specific drug formulation with claims likely aligned to the core active ingredient(s).
- Its patent rights are limited geographically to Brazil but are part of a broader international patent family.
- Competitor filings in Brazil and internationally suggest a competitive landscape, especially where drug innovation is sensitive.
- Patent validity depends on ongoing examination, prior art analysis, and potential opposition proceedings.
FAQs
1. Can BRPI0720178 be challenged for invalidity?
Yes. Post-grant oppositions or invalidity claims can be filed based on prior art or non-compliance with patentability criteria.
2. Does the patent cover the therapeutic use of the drug?
If claims include specific indications or methods of treatment, they are protected within the scope of those claims.
3. How broad are the patent claims?
The claims are designed to balance broad coverage of the core invention with specific embodiments to withstand invalidation attempts.
4. Are there similar patents outside Brazil?
Likely, as pharmaceutical companies typically file patents in multiple jurisdictions. Cross-referencing patent families via PCT publications provides insights.
5. What are the risks of patent infringement?
Infringement risk exists if third-party products fall within the scope of the claims. Enforcement depends on patent validity and clarity of scope.
References
- [1] World Intellectual Property Organization. (2022). Brazilian patent law overview. Retrieved from https://www.wipo.int
- [2] Brazilian Patent Office. (2018). Patent examination guidelines. Retrieved from https://gru.inpi.gov.br
- [3] European Patent Office. (2021). Comparative analysis of patent claim scope. Retrieved from https://www.epo.org
- [4] United States Patent and Trademark Office. (2022). Patent examination guidelines. Retrieved from https://www.uspto.gov
- [5] PatentScope. (2023). International patent family data. Retrieved from https://patentscope.wipo.int
